- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MRI for Traumatic Knee Injury Does Not Add to Improvement in Outcome
Magnetic resonance imaging, referred by general practitioners for traumatic knee injuries, adds to healthcare costs without improvement in outcomes.
Magnetic resonance imaging for traumatic knee injuries, referred by general practitioners, leads to higher healthcare costs without improvement in outcomes, according to a study published in the journal Radiology.
Researchers from the Netherlands performed a cost-utility analysis parallel to a prospective randomized controlled trial of 356 patients who presented with traumatic knee symptoms. The group, mean age 33 years (from 18 to 45), included 222 men.
A total of 177 patients were randomly assigned to usual care, which did not include MR imaging, but patients were referred to an orthopedic surgeon when conservative treatment was unsatisfactory. The remaining 179 patients were referred for MR imaging within two weeks after injury. Main outcome measures were quality-adjusted life years (QALYs) and costs from a healthcare and societal perspective.
The results showed mean QALYs were 0.888 in the MR imaging group and 0.899 in the usual care group. Healthcare costs per patient were higher in the MR imaging group (€1,109) than in the usual care group (€837), mainly due to higher costs for MR imaging, with no reduction in the number of referrals to an orthopedic surgeon in the MR imaging group.
The researchers concluded that referral for MR imaging referral by general practitioners was not cost-effective in patients with traumatic knee symptoms and that MR imaging led to more healthcare costs, without an improvement in health outcomes.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
